The Central Government has tightened rules for the sale of syrup-based medicines, making a valid doctor’s prescription mandatory for cough syrups and several other liquid formulations. The change follows an amendment to drug regulations that removes “Syrups” from the exemption list under Schedule K of the Drugs Rules, 1945, with the government citing patient safety, misuse concerns and the need for stronger oversight.
According to a notification issued by the Ministry of Health and Family Welfare, the Drugs (Fifth Amendment) Rules, 2026 have come into effect. The revised framework means syrup-based medicines can no longer be sold under the earlier exemption that allowed certain categories of medicines to be dispensed without a prescription.
FCRF’s Flagship Cyber Law Certification Returns With a New Four-Week Cohort
Schedule K Exemption Removed
Schedule K of the Drugs Rules, 1945 previously listed categories of medicines that could be sold under specified exemptions. With the latest amendment, syrups have been removed from that list, bringing them under tighter prescription-based control.
The immediate impact will be felt at medical stores and pharmacies, where cough syrups and other syrup-based medicines commonly purchased over the counter will now require prescription verification before sale.
The government has said the measure is intended to prevent unnecessary consumption and ensure that patients use such medicines under proper medical guidance. The move is also aimed at reducing risks linked to self-medication and incorrect dosage.
Misuse and Self-Medication Concerns Cited
Health officials have noted concerns over misuse of certain syrup formulations, improper dosage practices and unsupervised medicine use. Such risks can be higher for children, elderly persons and patients with existing medical conditions.
The revised rules seek to reduce the possibility of adverse health effects from medicines taken without professional advice. Experts in pharmaceutical regulation have also pointed to risks such as wrong treatment, drug interactions and unwanted side effects when medicines are purchased on self-diagnosis.
The ministry has stated that the decision followed a consultation process. A draft notification proposing the amendment was issued in December 2025, inviting comments and objections from stakeholders, including healthcare professionals, pharmaceutical companies, pharmacists and the public.
Pharmacies Face Higher Compliance Burden
Officials said recommendations from the Drugs Technical Advisory Board were considered before the amendment was finalized. The board is the country’s highest statutory body on technical matters related to drugs.
With the rules now in force, pharmacies and drug retailers will have to ensure that syrup-based medicines are dispensed only against valid prescriptions. They may also be required to maintain proper records wherever applicable under existing regulations.
State drug regulators and enforcement authorities are expected to monitor implementation of the new rules. The government has indicated that the revised framework is aimed at strengthening drug safety standards, curbing misuse and improving accountability in the sale of syrup-based medicines across the country.
